查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1381009

聚乙二醇化蛋白質市場：按產品類型、蛋白質類型、適應症、最終用戶 - 全球預測 2023-2030

PEGylated Proteins Market by Product (PEGylation Kits, PEGylation Reagents, Services), Protein Type (Colony-Stimulating Factor, Erythropoietin, Interferons), Indication, End-User - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

聚乙二醇化蛋白質市場預計將從 2022 年的 13 億美元增加到 2030 年的 28.1 億美元，預測期內年複合成長率為 10.04%。

聚乙二醇化蛋白質的全球市場

主要市場統計
市場金額：基準年 [2022] 13億美元
預計市場金額[2023] 14.3億美元
預計市場金額[2030] 28.1億美元
年複合成長率（%） 10.04%
聚乙二醇化蛋白市場-IMG1

FPNV定位矩陣

FPNV定位矩陣是評估聚乙二醇化蛋白質市場的重要工具。透過分析與業務策略和產品滿意度相關的關鍵指標來全面評估供應商。這使得使用者能夠根據自己的具體資訊做出明智的決策。進階分析將供應商分為四個像限，每個象限都有不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。這個富有洞察力的框架使決策者能夠充滿信心地駕馭市場。

市場佔有率分析

市場佔有率分析為供應商的市場形勢提供了寶貴的見解。評估對整體收益、客戶群和其他關鍵指標的影響可以全面了解公司的業績及其面臨的競爭環境。該分析還揭示了研究期間的競爭水平，例如市場佔有率成長、碎片化、主導地位和行業整合。

該報告對以下幾個方面提供了寶貴的見解：

1.市場滲透：提供有關市場動態和主要企業產品的全面資訊。

2. 市場開拓：詳細分析新興和成熟細分市場的滲透情況，以突顯利潤豐厚的商機。

3. 市場多元化：有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

5. 產品開發與創新：對未來技術、研發活動和突破性產品開發的智慧洞察。

本報告解決了以下關鍵問題：

1.聚乙二醇化蛋白市場的市場規模與預測是多少？

2.聚乙二醇化蛋白市場中哪些產品、細分市場、應用和領域具有最高的投資潛力？

3.聚乙二醇化蛋白市場的競爭策略窗口有哪些？

4.聚乙二醇化蛋白市場的最新技術趨勢和法律規範是什麼？

5.聚乙二醇化蛋白市場主要廠商的市場佔有率是多少？

6.進入聚乙二醇化蛋白市場的適當型態和策略手段是什麼？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 人口中慢性病盛行率上升
      • 加大藥品研發項目的投資
      • 實現整個經濟領域醫療基礎設施的現代化
    • 抑制因素
      • 聚乙二醇化過程相關的高成本
    • 機會
      • 更重視生物技術與生物分子工程
      • 聚乙二醇化在標靶特異性藥物傳遞的潛力
    • 任務
      • 嚴格而漫長的醫藥品認證過程
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章 聚乙二醇化蛋白市場：依產品

  • 聚乙二醇化試劑盒
  • 聚乙二醇化試劑
    • 生物功能聚乙二醇
    • 支鏈聚乙二醇
    • 單官能線性 PEG
    • 多臂聚乙二醇
  • 服務

第7章 按蛋白質類型分類的聚乙二醇化蛋白質市場

  • 集落刺激因子
  • 促紅血球生成素
  • 干擾素
  • 單株抗體
  • 重組因子VII

第8章 聚乙二醇化蛋白市場（按適應症）

  • 自體免疫疾病
  • 癌症
  • 胃腸道疾病
  • 血友病
  • 肝炎
  • 多發性硬化症

第9章 聚乙二醇化蛋白質市場：依最終用戶分類

  • 學術研究所
  • CRO
  • 製藥和生物製藥公司

第10章 美洲聚乙二醇化蛋白市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區聚乙二醇化蛋白市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲聚乙二醇化蛋白市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第14章競爭產品組合

  • 主要公司簡介
    • Abcam PLC
    • Aurigene Pharmaceutical Services Limited
    • Biogen Inc.
    • BioMarin
    • Biomatrik Inc.
    • Celares GmbH
    • Creative PEGWorks
    • Enzon Pharmaceuticals, Inc.
    • Exelead
    • F. Hoffmann-La Roche Ltd.
    • Horizon Therapeutics PLC
    • Iris Biotech GmbH
    • JenKem Technology USA Inc.
    • Laysan Bio, Inc.
    • Ligand Pharmaceuticals Inc
    • Merck KGaA
    • NOF CORPORATION
    • Novo Nordisk A/S
    • Pfizer Inc.
    • Profacgen
    • Quanta BioDesign Ltd
    • QuiaPEG Pharmaceuticals Holding AB
    • Takeda Pharmaceuticals Company Limited
    • Thermo Fisher Scientific Inc.
    • UCB SA
  • 主要產品系列

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-69324464D11D

The PEGylated Proteins Market is projected to reach USD 2.81 billion by 2030 from USD 1.30 billion in 2022, at a CAGR of 10.04% during the forecast period.

Global PEGylated Proteins Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 1.30 billion
Estimated Year Value [2023] USD 1.43 billion
Forecast Year Value [2030] USD 2.81 billion
CAGR (%) 10.04%
PEGylated Proteins Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the PEGylated Proteins Market.

Based on Product, market is studied across PEGylation Kits, PEGylation Reagents, and Services. The PEGylation Reagents is further studied across Biofunctional PEGs, Branched PEGs, Monofunctional Linear PEGs, and Multi-Arm PEGs. The PEGylation Reagents is projected to witness significant market share during forecast period.

Based on Protein Type, market is studied across Colony-Stimulating Factor, Erythropoietin, Interferons, mAbs, and Recombinant Factor VII. The Colony-Stimulating Factor is projected to witness significant market share during forecast period.

Based on Indication, market is studied across Autoimmune Diseases, Cancer, Gastrointestinal Disorders, Hemophilia, Hepatitis, and Multiple Sclerosis. The Autoimmune Diseases is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Academic & Research Institutes, CROs, and Pharmaceutical & Biopharmaceutical Companies. The CROs is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the PEGylated Proteins Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape PEGylated Proteins Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the PEGylated Proteins Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Aurigene Pharmaceutical Services Limited, Biogen Inc., BioMarin, Biomatrik Inc., Celares GmbH, Creative PEGWorks, Enzon Pharmaceuticals, Inc., Exelead, F. Hoffmann-La Roche Ltd., Horizon Therapeutics PLC, Iris Biotech GmbH, JenKem Technology USA Inc., Laysan Bio, Inc., Ligand Pharmaceuticals Inc, Merck KGaA, NOF CORPORATION, Novo Nordisk A/S, Pfizer Inc., Profacgen, Quanta BioDesign Ltd, QuiaPEG Pharmaceuticals Holding AB, Takeda Pharmaceuticals Company Limited, Thermo Fisher Scientific Inc., and UCB S.A..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the PEGylated Proteins Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the PEGylated Proteins Market?

3. What is the competitive strategic window for identifying opportunities in the PEGylated Proteins Market?

4. What are the latest technology trends and regulatory frameworks in the PEGylated Proteins Market?

5. What is the market share of the leading vendors in the PEGylated Proteins Market?

6. Which modes and strategic moves are suitable for entering the PEGylated Proteins Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. PEGylated Proteins Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic diseases among population
      • 5.1.1.2. Growing investments in pharmaceutical research and development programs
      • 5.1.1.3. Modernization of healthcare infrastructure across economies
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with PEGylation process
    • 5.1.3. Opportunities
      • 5.1.3.1. Higher emphasis on biotechnology and biomolecular engineering
      • 5.1.3.2. Potential of PEGylation in target specific drug delivery
    • 5.1.4. Challenges
      • 5.1.4.1. Time consuming stringent drug approval processes
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. PEGylated Proteins Market, by Product

  • 6.1. Introduction
  • 6.2. PEGylation Kits
  • 6.3. PEGylation Reagents
    • 6.4.1. Biofunctional PEGs
    • 6.4.2. Branched PEGs
    • 6.4.3. Monofunctional Linear PEGs
    • 6.4.4. Multi-Arm PEGs
  • 6.4. Services

7. PEGylated Proteins Market, by Protein Type

  • 7.1. Introduction
  • 7.2. Colony-Stimulating Factor
  • 7.3. Erythropoietin
  • 7.4. Interferons
  • 7.5. mAbs
  • 7.6. Recombinant Factor VII

8. PEGylated Proteins Market, by Indication

  • 8.1. Introduction
  • 8.2. Autoimmune Diseases
  • 8.3. Cancer
  • 8.4. Gastrointestinal Disorders
  • 8.5. Hemophilia
  • 8.6. Hepatitis
  • 8.7. Multiple Sclerosis

9. PEGylated Proteins Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. CROs
  • 9.4. Pharmaceutical & Biopharmaceutical Companies

10. Americas PEGylated Proteins Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific PEGylated Proteins Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa PEGylated Proteins Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Abcam PLC
    • 14.1.2. Aurigene Pharmaceutical Services Limited
    • 14.1.3. Biogen Inc.
    • 14.1.4. BioMarin
    • 14.1.5. Biomatrik Inc.
    • 14.1.6. Celares GmbH
    • 14.1.7. Creative PEGWorks
    • 14.1.8. Enzon Pharmaceuticals, Inc.
    • 14.1.9. Exelead
    • 14.1.10. F. Hoffmann-La Roche Ltd.
    • 14.1.11. Horizon Therapeutics PLC
    • 14.1.12. Iris Biotech GmbH
    • 14.1.13. JenKem Technology USA Inc.
    • 14.1.14. Laysan Bio, Inc.
    • 14.1.15. Ligand Pharmaceuticals Inc
    • 14.1.16. Merck KGaA
    • 14.1.17. NOF CORPORATION
    • 14.1.18. Novo Nordisk A/S
    • 14.1.19. Pfizer Inc.
    • 14.1.20. Profacgen
    • 14.1.21. Quanta BioDesign Ltd
    • 14.1.22. QuiaPEG Pharmaceuticals Holding AB
    • 14.1.23. Takeda Pharmaceuticals Company Limited
    • 14.1.24. Thermo Fisher Scientific Inc.
    • 14.1.25. UCB S.A.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. PEGYLATED PROTEINS MARKET RESEARCH PROCESS
  • FIGURE 2. PEGYLATED PROTEINS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. PEGYLATED PROTEINS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. PEGYLATED PROTEINS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. PEGYLATED PROTEINS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. PEGYLATED PROTEINS MARKET DYNAMICS
  • FIGURE 7. PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 8. PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2022 VS 2030 (%)
  • FIGURE 10. PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
  • FIGURE 12. PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 14. PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 16. AMERICAS PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES PEGYLATED PROTEINS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 18. UNITED STATES PEGYLATED PROTEINS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 23. PEGYLATED PROTEINS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 24. PEGYLATED PROTEINS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. PEGYLATED PROTEINS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. PEGYLATED PROTEINS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 9. PEGYLATED PROTEINS MARKET SIZE, BY BIOFUNCTIONAL PEGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. PEGYLATED PROTEINS MARKET SIZE, BY BRANCHED PEGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. PEGYLATED PROTEINS MARKET SIZE, BY MONOFUNCTIONAL LINEAR PEGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. PEGYLATED PROTEINS MARKET SIZE, BY MULTI-ARM PEGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. PEGYLATED PROTEINS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. PEGYLATED PROTEINS MARKET SIZE, BY COLONY-STIMULATING FACTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. PEGYLATED PROTEINS MARKET SIZE, BY ERYTHROPOIETIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. PEGYLATED PROTEINS MARKET SIZE, BY INTERFERONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. PEGYLATED PROTEINS MARKET SIZE, BY MABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. PEGYLATED PROTEINS MARKET SIZE, BY RECOMBINANT FACTOR VII, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 21. PEGYLATED PROTEINS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. PEGYLATED PROTEINS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. PEGYLATED PROTEINS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. PEGYLATED PROTEINS MARKET SIZE, BY HEMOPHILIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. PEGYLATED PROTEINS MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. PEGYLATED PROTEINS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. PEGYLATED PROTEINS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. PEGYLATED PROTEINS MARKET SIZE, BY CROS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. PEGYLATED PROTEINS MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES PEGYLATED PROTEINS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. PEGYLATED PROTEINS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 241. PEGYLATED PROTEINS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 242. PEGYLATED PROTEINS MARKET LICENSE & PRICING